Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 20, Number 6—June 2014

Human Polyomavirus 9 Infection in Kidney Transplant Patients

Els van der MeijdenComments to Author , Herman F. Wunderink, Caroline S. van der Blij-de Brouwer, Hans L. Zaaijer, Joris I. Rotmans, Jan Nico Bouwes Bavinck, and Mariet C.W. Feltkamp
Author affiliations: Leiden University Medical Center, Leiden, the Netherlands (E. van der Meijden, H.F. Wunderink, C.S. van der Blij-de Brouwer, J.I. Rotmans, J.N. Bouwes Bavinck, M.C.W. Feltkamp); Sanquin Blood Supply Foundation, Amsterdam, the Netherlands (H.L. Zaaijer)

Main Article

Table 1

Characteristics of patients and controls for study of human polyomavirus 9 prevalence among kidney transplant patients, the Netherlands*

Characteristic Transplant patient type
Blood donors
All Kidney Kidney–pancreas p value
Patients and controls 101 83 (82) 18 (18) 87
Mean age, y (range)
47 (21–74)
48 (21–74)
43 (30–54)
52 (29–68)
F 34 (34) 27 (33) 7 (39) 0.605‡ 31 (36)
M 67 (66) 56 (67) 11(61) 56 (64)

*Values are no. (%) except as indicated.
†Comparison of kidney and kidney–pancreas patient groups; Student t test.
‡Comparison of kidney and kidney–pancreas patient groups; χ2 test.

Main Article

Page created: March 28, 2014
Page updated: March 28, 2014
Page reviewed: March 28, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.